메뉴 건너뛰기




Volumn 28, Issue 8, 2011, Pages 718-720

Iron chelation therapy with deferasirox results in recovery of hematopoiesis in a child with aplastic anemia

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DEFERASIROX; FERRITIN; HEMOGLOBIN; THYMOCYTE ANTIBODY;

EID: 80055018836     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2011.615050     Document Type: Letter
Times cited : (10)

References (7)
  • 1
    • 70450219836 scopus 로고    scopus 로고
    • Deferasirox (Exjade) for the treatment of iron overload
    • Cappellini MD, Taher A. Deferasirox (Exjade) for the treatment of iron overload. Acta Haematol. 2009;122:165-173.
    • (2009) Acta Haematol , vol.122 , pp. 165-173
    • Cappellini, M.D.1    Taher, A.2
  • 2
    • 77950917096 scopus 로고    scopus 로고
    • Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patientwithmyelodysplastic syndrome
    • Nishiuchi T, Okutani Y, Fujita T, et al. Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patientwithmyelodysplastic syndrome. Int J Hematol. 2010;91:333-335.
    • (2010) Int J Hematol , vol.91 , pp. 333-335
    • Nishiuchi, T.1    Okutani, Y.2    Fujita, T.3
  • 3
    • 34248594152 scopus 로고    scopus 로고
    • Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670)
    • DOI 10.1111/j.1600-0609.2007.00840.x
    • Di Tucci AA, Murru R, Alberti D, et al. Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). Eur J Haematol. 2007;78:540-542. (Pubitemid 46753589)
    • (2007) European Journal of Haematology , vol.78 , Issue.6 , pp. 540-542
    • Di Tucci, A.A.1    Murru, R.2    Alberti, D.3    Rabault, B.4    Deplano, S.5    Angelucci, E.6
  • 4
    • 70350300992 scopus 로고    scopus 로고
    • Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy
    • Taher AT,Musallam KM, Koussa S, Inati A. Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy. Ann Hematol. 2009;88:1263-1264.
    • (2009) Ann Hematol , vol.88 , pp. 1263-1264
    • Taher, A.T.1    Musallam, K.M.2    Koussa, S.3    Inati, A.4
  • 5
    • 77954338182 scopus 로고    scopus 로고
    • Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients
    • Oliva EN, Ronco F, Marino A, et al. Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients. Transfusion. 2010;50:1568-1570.
    • (2010) Transfusion , vol.50 , pp. 1568-1570
    • Oliva, E.N.1    Ronco, F.2    Marino, A.3
  • 6
    • 77954253063 scopus 로고    scopus 로고
    • Deferasirox treatment interruption in a transfusion-requiring myelodysplastic patient led to loss of erythroid response
    • Breccia M, Loglisci G, Salaroli A, et al. Deferasirox treatment interruption in a transfusion-requiring myelodysplastic patient led to loss of erythroid response. Acta Haematol. 2010;124:46-48.
    • (2010) Acta Haematol , vol.124 , pp. 46-48
    • Breccia, M.1    Loglisci, G.2    Salaroli, A.3
  • 7
    • 0023576003 scopus 로고
    • Incidence of aplastic anemia: The relevance of diagnostic criteria
    • International Agranulocytosis andAplastic Anemia Study
    • International Agranulocytosis andAplastic Anemia Study. Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood. 1987;70:1718-1721.
    • (1987) Blood , vol.70 , pp. 1718-1721


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.